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Abstract
The aim of this study was to determine whether exogenous administration of C-type 
natriuretic peptide (CNP) induces functional and morphological vascular changes in 
spontaneously hypertensive rats (SHR) compared with normotensive rats. Male 12-
week-old normotensive Wistar and SHR were administered with saline (NaCl 0.9%) or 
CNP (0.75 μg/h/100 g) for 14 days (subcutaneous micro-osmotic pumps). Systolic 
blood pressure (SBP) was measured in awake animals and renal parameters were 
evaluated. After decapitation, the aorta was removed, and vascular morphology, 
profibrotic markers, and vascular reactivity were measured. In addition, nitric oxide 
(NO) system and oxidative stress were evaluated. After 14-days of treatment, CNP 
effectively reduced SBP in SHR without changes in renal function. CNP attenuated 
vascular remodeling in hypertensive rats, diminishing both profibrotic and pro-
inflammatory cytokines. Also, CNP activated the vascular NO system and exerted an 
antioxidant effect in aortic tissue of both groups, diminishing superoxide production 
and thiobarbituric acid-reactive substances, and increasing glutathione content. These 
results show that chronic treatment with CNP attenuates the vascular damage 
development in a model of essential hypertension, inducing changes in fibrotic, 
inflammatory, oxidative, and NO pathways that could contribute to beneficial long-
term effects on vascular morphology, extracellular matrix composition, and function. 
The knowledge of these effects of CNP could lead to improved therapeutic strategies to 
not only control BP but also reduce vascular damage, primarily responsible for the risk 
of cardiovascular events.
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